BioSpace News Archive

ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, has announced the finalization of national agreements with top German Statutory Health Insurers (“SHI”) Techniker Krankenkasse (“TK”) and Deutsche Angestellten-Krankenkasse – Gesundheit (“DAK-Gesundheit”).

The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing specialty pharmacy industry stakeholders, named former NFL quarterback and Pro Football Hall of Fame member Jim Kelly as a keynote speaker for the 2020 NASP Annual Meeting & Expo.

The ProPath Immunohistochemistry (IHC) division is one of the most sophisticated specialty laboratories in the country.

Dr. Poznansky will answer pre-submitted questions from investors at the conclusion of the call

Novant Health will resume some non-time sensitive and non-emergent surgeries and procedures beginning Monday, May 4. Additionally, clinics will reinstate appointments that were previously delayed by phasing in visits starting with pediatric well checks, chronic disease and acute issue visits.

Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has been actively analyzing the current pharma landscape and the impact of the ongoing crisis on pharmaceutical warehousing and transport.

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company’s drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspection and the company has received two EU GMP Certificates (Certificate of GMP Compliance of a Manufacturer) from Poland’s Chief Pharmaceutical Inspector.

ScholarRx today announced a new partnership with SOMA, the Student Osteopathic Medical Association, which represents the largest network of osteopathic medical students in the United States.

Monteris Medical, a pioneer and leader in the market for minimally invasive, image-guided laser ablation systems, announced today that results from a multicenter clinical study of its NeuroBlate® System have been published in the peer-reviewed journal Neurosurgery

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 30 million members nationally, has named Kyle Skiermont, PharmD, as senior vice president, specialty pharmacy and home delivery services.